This means that the greater increase in plasma insulin concentration in response to oral glucose challenge in overweight and obese individuals with NAFLD compared with those observed in the lean NL group is due to increased insulin secretion rather than to a reduction in total insulin extraction by the liver or extrahepatic tissues. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.